Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA251385
Max Phase: Preclinical
Molecular Formula: C62H105N9O38S
Molecular Weight: 1616.61
Molecule Type: Small molecule
Associated Items:
ID: ALA251385
Max Phase: Preclinical
Molecular Formula: C62H105N9O38S
Molecular Weight: 1616.61
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC(=O)CN(CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C(=O)CN(CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C(=O)CN(CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C(=O)CN(CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C(=O)CN(CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C(=O)CNC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12
Standard InChI: InChI=1S/C62H105N9O38S/c63-34(77)16-67(5-10-100-57-52(94)47(89)42(84)28(21-72)105-57)37(80)18-69(7-12-102-59-54(96)49(91)44(86)30(23-74)107-59)39(82)20-71(9-14-104-61-56(98)51(93)46(88)32(25-76)109-61)40(83)19-70(8-13-103-60-55(97)50(92)45(87)31(24-75)108-60)38(81)17-68(6-11-101-58-53(95)48(90)43(85)29(22-73)106-58)36(79)15-64-35(78)4-2-1-3-33-41-27(26-110-33)65-62(99)66-41/h27-33,41-61,72-76,84-98H,1-26H2,(H2,63,77)(H,64,78)(H2,65,66,99)/t27-,28+,29+,30+,31+,32+,33?,41-,42+,43+,44+,45+,46+,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-/m0/s1
Standard InChI Key: FSMVVJIAEWRFMV-HJDUBOQZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1616.61 | Molecular Weight (Monoisotopic): 1615.6281 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Yuasa H, Honma H, Hashimoto H, Tsunooka M, Kojima-Aikawa K.. (2007) Pentamer is the minimum structure for oligomannosylpeptoids to bind to concanavalin A., 17 (18): [PMID:17689075] [10.1016/j.bmcl.2006.12.075] |
Source(1):